RadNet, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
RadNet, Inc. (RDNT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $8.90 per share for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-08-11
- RadNet, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $10.11, a 60.48% increase year-over-year.
- RadNet, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $6.30, a 37.62% decline year-over-year.
- RadNet, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $10.10.
- RadNet, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $9.52, a 14.31% decline from fiscal 2023.
- RadNet, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $11.11, a 5.45% decline from fiscal 2022.
- RadNet, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $11.75.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-06-30 | $8.90 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | $10.11 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | $9.52 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $6.15 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $6.15 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | $6.30 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $11.11 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $8.46 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $10.10 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $10.10 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $11.75 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |